G. Initiative and . Asthma, Global strategy for asthma management and prevention. NHLBI/WHO Workshop report, National Institutes of Health, 1995.

G. Initiative and . Asthma, Global strategy for asthma management and prevention. NHLBI/WHO Workshop report. Bethesda, MD: National Institutes of Health Publication No. 95?3659 updated 2002, 2008.

O. Byrne, P. Barnes, P. Rodriguez-roisin, R. Runnerstrom, E. Sandstrom et al., Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma, American Journal of Respiratory and Critical Care Medicine, vol.164, issue.8, pp.1392-1397, 2001.
DOI : 10.1164/ajrccm.164.8.2104102

L. Irvine, I. Crombie, E. Alder, R. Neville, and R. Clark, What predicts poor collection of medication among children with asthma? A case-control study, European Respiratory Journal, vol.20, issue.6, pp.1464-1469, 2002.
DOI : 10.1183/09031936.02.00302102

P. Kuna, M. Peters, A. Manjra, C. Jorup, I. Naya et al., Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations, International Journal of Clinical Practice, vol.28, issue.Suppl. 50, pp.725-736, 2007.
DOI : 10.1111/j.1742-1241.2007.01338.x

E. Bateman, H. Boushey, J. Bousquet, W. Busse, T. Clark et al., Can Guideline-defined Asthma Control Be Achieved?, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.8, pp.836-844, 2004.
DOI : 10.1164/rccm.200401-033OC

I. Greenstone, N. Chroinin, M. Masse, V. Danish, A. Magdalinos et al., Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma, Cochrane Database Syst Rev, vol.25, issue.937, p.5533, 2005.
DOI : 10.1002/14651858.CD005533

M. Masoli, M. Weatherall, S. Holt, and R. Beasley, Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma, Thorax, vol.60, issue.9, pp.730-734, 2005.
DOI : 10.1136/thx.2004.039180

H. Nelson, S. Weiss, E. Bleecker, S. Yancey, and P. Dorinsky, The Salmeterol Multicenter Asthma Research Trial, Chest, vol.129, issue.1, pp.15-26, 2006.
DOI : 10.1378/chest.129.1.15

M. Mann, B. Chowdhury, E. Sullivan, R. Nicklas, R. Anthracite et al., Serious Asthma Exacerbations in Asthmatics Treated With High-Dose Formoterol, Chest, vol.124, issue.1, pp.70-74, 2003.
DOI : 10.1378/chest.124.1.70

H. Nelson, Long-Acting Beta-Agonists in Adult Asthma: Evidence that these Drugs are Safe, Primary Care Respiratory Journal, vol.15, issue.5, pp.271-277, 2006.
DOI : 10.1016/j.pcrj.2006.08.006

A. Woolcock, B. Lundback, N. Ringdal, and L. Jacques, Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids., American Journal of Respiratory and Critical Care Medicine, vol.153, issue.5, pp.1481-1488, 1996.
DOI : 10.1164/ajrccm.153.5.8630590

A. Greening, P. Ind, M. Northfield, and G. Shaw, Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid, The Lancet, vol.344, issue.8917, pp.219-224, 1994.
DOI : 10.1016/S0140-6736(94)92996-3

R. Pauwels, C. Lofdahl, D. Postma, A. Tattersfield, O. Byrne et al., Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma, New England Journal of Medicine, vol.337, issue.20, pp.1405-1411, 1997.
DOI : 10.1056/NEJM199711133372001

O. Byrne, P. Bisgaard, H. Godard, P. Pistolesi, M. Palmqvist et al., Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.2, pp.129-136, 2005.
DOI : 10.1164/rccm.200407-884OC

M. Thomas, J. Von-zeigenweidt, A. Lee, and D. Price, High-dose inhaled corticosteroids versus add-on long-acting ??-agonists in asthma: An observational study, Journal of Allergy and Clinical Immunology, vol.123, issue.1, pp.116-121, 2009.
DOI : 10.1016/j.jaci.2008.09.035

M. Sears, Step-up therapy in uncontrolled asthma: Choices and outcomes, Journal of Allergy and Clinical Immunology, vol.123, issue.1, pp.122-123, 2009.
DOI : 10.1016/j.jaci.2008.10.045

R. Green, C. Brightling, S. Mckenna, B. Hargadon, D. Parker et al., Asthma exacerbations and sputum eosinophil counts, The Lancet, vol.361, issue.9365, pp.1715-1721, 2002.
DOI : 10.1016/S0140-6736(03)13009-7